Enfiera 500 mg Injection
$386,71
$301,64
Enfiera 500 mg Injection is a targeted monoclonal antibody designed to address various immune system-related conditions, making it a vital option in oncology. This medication primarily treats specific types of cancer, notably non-Hodgkin's lymphoma and chronic lymphocytic leukemia, by binding to particular proteins on the surface of cancer cells, which helps the immune system identify and eliminate these abnormal cells more effectively. Patients should be aware of potential side effects, including infusion reactions, increased risk of infections, and other serious complications, necessitating careful monitoring by healthcare providers. It’s important for individuals receiving Enfiera to discuss their full medical history and any current medications with their doctor to avoid adverse interactions. Additionally, the use of this injection may not be suitable for patients with certain pre-existing conditions, so a thorough evaluation is essential. By leveraging the power of the immune system, Enfiera represents a significant advancement in cancer treatment, fostering hope for patients battling these challenging diseases. This innovative therapy underscores the importance of personalized medicine in modern oncology, aiming to improve patient outcomes and quality of life. Always consult with a healthcare professional to ensure that Enfiera 500 mg Injection aligns with your treatment plan.
數量
Active Pharmaceutical Ingredient
Uses
• Enfiera 500 mg injection is utilized in the treatment of Non-Hodgkin lymphoma (NHL). This medication helps to manage the symptoms associated with this type of cancer effectively. By targeting specific cells, Enfiera 500 mg injection aids in reducing the proliferation of malignant cells. Patients receiving this treatment may experience improved quality of life as their condition stabilizes.
• In cases of rheumatoid arthritis, Enfiera 500 mg injection plays a crucial role in controlling inflammation and joint damage. This medication assists in alleviating pain and improving mobility in affected individuals. By modulating the immune response, Enfiera 500 mg injection helps to reduce the severity of symptoms. Regular administration can lead to better long-term outcomes for patients with this chronic condition.
• Enfiera 500 mg injection is also effective in treating chronic lymphocytic leukaemia, a type of blood cancer. This medication works by targeting cancerous cells, thereby helping to manage the disease and prolong survival. Patients receiving Enfiera 500 mg injection may see a decrease in the number of abnormal cells in their bloodstream. This can lead to an overall improvement in health status and daily functioning.
• Additionally, Enfiera 500 mg injection is indicated for granulomatosis with polyangiitis and microscopic polyangiitis. These conditions involve inflammation of blood vessels and can lead to serious complications. By using Enfiera 500 mg injection, clinicians aim to control the inflammatory processes and prevent further organ damage. This treatment is vital in achieving remission and maintaining patient well-being.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Enfiera 500 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician. Rheumatoid arthritis: Enfiera 500 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician. Blood cancer (Chronic lymphocytic leukaemia): Leukaemia, also known as blood cancer, is a malignant neoplasm of the haematopoietic tissues that impairs the body's ability to combat infection. Enfiera 500 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukaemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment. Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Enfiera 500 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA. Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Enfiera 500 Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Enfiera 500 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Enfiera 500 mg Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Enfiera 500 mg. Please consult your doctor.
• Kidney: Enfiera 500 Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Enfiera 500 mg Injection is likely to be safe to use while breast-feeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Enfiera 500 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Enfiera 500 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Enfiera 500 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.